Expertise in
7
conditions

Dr. Mark L. Warren

Endocrinology
Physicians East PA
1006 Wh Smith Blvd, 
Greenville, NC 
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
7
conditions
Physicians East PA
1006 Wh Smith Blvd, 
Greenville, NC 

Overview

Mark Warren is an Endocrinologist practicing medicine in Greenville, North Carolina.

Dr. Warren is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Hypoparathyroidism, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), and Low Blood Sugar.

He is actively involved in clinical research, co-authoring 29 peer reviewed articles and participating in 12 clinical trials. Dr. Warren is currently accepting new patients.

Specialties

Endocrinology

Licenses

Internal Medicine in NC

Hospital Affiliations

Ecu Health Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Physicians East PA
1006 Wh Smith Blvd, Greenville, NC 27834

Additional Areas of Focus

Dr. Warren has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
Enrollment Status: Completed
Publish Date: July 14, 2026
Intervention Type: Other
In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2 - Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes
In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2 - Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes
Enrollment Status: Completed
Publish Date: April 16, 2026
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp® (Insulin Aspart Injection)
Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp® (Insulin Aspart Injection)
Enrollment Status: Completed
Publish Date: June 22, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Post- Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System
A Post- Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System
Enrollment Status: Completed
Publish Date: June 12, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Enrollment Status: Completed
Publish Date: June 03, 2025
Intervention Type: Drug
Study Phase: Phase 2
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc
Enrollment Status: Completed
Publish Date: January 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Biological
Study Drug: rhPTH(1-84)
Study Phase: Phase 4
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Combination product
Study Drugs: Abaloparatide solid microstructured transdermal system, Abaloparatide subcutaneous
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Enrollment Status: Completed
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D
Enrollment Status: Completed
Publish Date: May 01, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 9 Less Clinical Trials

29 Total Publications

Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.
Journal: Diabetes technology & therapeutics
Published: April 29, 2026
Similar Doctors
Expertise in
26
conditions
Expertise in
26
conditions
Referral required
Before you request

ECU Health Medical Center

2100 Stantonsburg Rd, 
Greenville, NC 
 (0.6 miles away)
252-847-4100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Almond Drake-Iii is an Endocrinologist practicing medicine in Greenville, North Carolina. Dr. Drake-Iii is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Thyroid Cancer, and Papillary Thyroid Cancer. Dr. Drake-Iii is currently accepting new patients.

Expertise in
44
conditions
Dr. Nilay V. Desai
Endocrinology
Expertise in
44
conditions
Dr. Nilay V. Desai
Endocrinology
Referral required
Before you request

Office

102 S Eastpointe Ave, 
Nashville, NC 
 (39.4 miles away)
252-459-4012
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nilay Desai is an Endocrinologist practicing medicine in Nashville, North Carolina. Dr. Desai is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Toxic Nodular Goiter, Thyroid Storm, and Hyperthyroidism. Dr. Desai is currently accepting new patients.

Expertise in
37
conditions
Dr. Sujani Poonuru
Endocrinology
Expertise in
37
conditions
Dr. Sujani Poonuru
Endocrinology
Referral required
Before you request

Boice-Willis Clinic PA

901 N Winstead Ave, 
Rocky Mount, NC 
 (36.0 miles away)
252-937-0200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sujani Poonuru is an Endocrinologist practicing medicine in Rocky Mount, North Carolina. Dr. Poonuru is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses Hyperthyroidism, Thyroid Storm, Milk-Alkali Syndrome, and Hypercalcemia. Dr. Poonuru is currently accepting new patients.

Frequently Asked Questions about Dr. Mark L. Warren

How do I make an appointment with Dr. Mark L. Warren?

You can book an appointment with Dr. Mark L. Warren by calling their office at 252-413-6683. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark L. Warren a top-rated expert for Hypoparathyroidism?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark L. Warren is classified as an Distinguished expert for Hypoparathyroidism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark L. Warren specialize in?

While Dr. Mark L. Warren is a Endocrinology, they have specific expertise in Hypoparathyroidism, Type 2 Diabetes (T2D), and Type 1 Diabetes (T1D). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. Mark L. Warren participate in research or clinical trials?

Yes. Dr. Mark L. Warren has published 29 articles and abstracts on conditions like Hypoparathyroidism. You can view a list of Dr. Mark L. Warren's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark L. Warren accept my insurance?

Dr. Mark L. Warren accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 252-413-6683 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Warren's expertise for a condition
ConditionClose
    View All 36 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile